Source Name	Characteristics[organism]	Characteristics[organism part]	Characteristics[age]	Characteristics[developmental stage]	Characteristics[cell line]	Characteristics[cell type]	Characteristics[ancestry category]	Characteristics[sex]	Characteristics[disease]	Characteristics[individual]	Material Type	assay name	Technology Type	comment[label]	comment[file uri]	comment[instrument]	comment[fractionation method]	comment[fraction identifier]	comment[separation]	comment[dissociation method]	comment[collision energy]	comment[cleavage agent details]	comment[modification parameters]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[data file]	factor value[organism part]
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC20	tissue	run 1	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_60_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_60_1.raw	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC20	tissue	run 2	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_60_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_60_2.raw	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC20	tissue	run 3	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_60_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_60_3.raw	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC20	tissue	run 4	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_60_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_60_4.raw	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC20	tissue	run 5	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_60_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_60_5.raw	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC20	tissue	run 6	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_60_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_60_6.raw	prostate tumors tissue
Sample 2	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC21	tissue	run 7	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_61_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_61_1.raw	non-malignant prostate tissue
Sample 2	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC21	tissue	run 8	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_61_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_61_2.raw	non-malignant prostate tissue
Sample 2	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC21	tissue	run 9	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_61_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_61_3.raw	non-malignant prostate tissue
Sample 2	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC21	tissue	run 10	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_61_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_61_4.raw	non-malignant prostate tissue
Sample 2	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC21	tissue	run 11	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_61_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_61_5.raw	non-malignant prostate tissue
Sample 2	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC21	tissue	run 12	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_61_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_61_6.raw	non-malignant prostate tissue
Sample 3	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC21	tissue	run 13	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_62_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_62_1.raw	non-malignant prostate tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC26	tissue	run 14	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_62_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_62_2.raw	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC26	tissue	run 15	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_62_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_62_3.raw	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC26	tissue	run 16	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_62_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_62_4.raw	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC26	tissue	run 17	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_62_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_62_5.raw	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC26	tissue	run 18	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_62_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_62_6.raw	prostate tumors tissue
Sample 4	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC26	tissue	run 19	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_63_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_63_1.raw	prostate tumors tissue
Sample 4	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC27	tissue	run 20	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_63_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_63_2.raw	non-malignant prostate tissue
Sample 4	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC27	tissue	run 21	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_63_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_63_3.raw	non-malignant prostate tissue
Sample 4	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC27	tissue	run 22	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_63_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_63_4.raw	non-malignant prostate tissue
Sample 4	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC27	tissue	run 23	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_63_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_63_5.raw	non-malignant prostate tissue
Sample 4	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC27	tissue	run 24	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_63_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_63_6.raw	non-malignant prostate tissue
Sample 5	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC27	tissue	run 25	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_64_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_64_1.raw	non-malignant prostate tissue
Sample 5	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC28	tissue	run 26	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_64_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_64_2.raw	prostate tumors tissue
Sample 5	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC28	tissue	run 27	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_64_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_64_3.raw	prostate tumors tissue
Sample 5	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC28	tissue	run 28	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_64_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_64_4.raw	prostate tumors tissue
Sample 5	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC28	tissue	run 29	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_64_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_64_5.raw	prostate tumors tissue
Sample 5	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC28	tissue	run 30	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003636/20120511_EXQ6_DiIg_SA_PCA_64_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20120511_EXQ6_DiIg_SA_PCA_64_6.raw	prostate tumors tissue
